logo
logo
Sign in

Fetal DNA sequencing is fastest growing segment fueling the growth of Preeclampsia Diagnostics Market

avatar
naufan
Fetal DNA sequencing is fastest growing segment fueling the growth of Preeclampsia Diagnostics Market

Market Overview:

Preeclampsia diagnostics products include blood pressure monitoring devices, urine analysis kits, and fetal DNA sequencing kits. Regular monitoring of blood pressure and urine analysis helps detect signs of preeclampsia at an early stage. Fetal DNA sequencing aids in non-invasive fetal DNA screening and diagnosis of genetic disorders in the fetus.

The Preeclampsia Diagnostics market is estimated to be valued at US$ 1,587.53 Mn or Mn in 2023 and is expected to exhibit a CAGR of 11.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Growing preference for non-invasive prenatal diagnostic techniques like fetal cell-free DNA analysis is fueling the market growth. Fetal DNA sequencing allows early screening for genetic abnormalities in the fetus without any risk to the mother or fetus. It has the potential to diagnose genetic disorders in fetal cells found in maternal blood. This emerging technology is replacing invasive diagnostic techniques like amniocentesis and placental biopsy. Growing demand for early diagnostics and rising focus on preventive healthcare are further expected to drive the demand for fetal DNA sequencing kits over the forecast period.

Segment Analysis

The global preeclampsia diagnostics market is segmented by product type, method, test type and end-user. Based on product type, consumables and assays kits segment dominated the market in 2022. This is due to the recurring requirement of assay kits and consumables for preeclampsia diagnosis on a regular basis. Based on method, the proteinuria tests segment accounted for the largest share in 2022. This is because proteinuria tests are widely used for the preliminary screening and detection of preeclampsia during pregnancy checkups.

Key Takeaways

The Global Preeclampsia Diagnostics Market Size is expected to witness high growth, exhibiting a CAGR of 11% over the forecast period, due to increasing prevalence of preeclampsia among pregnant women worldwide.

Regional analysis

North America dominated the global market in 2022 and is expected to maintain its dominance over the forecast period. This is attributed to the rising incidence of preeclampsia and high awareness regarding prenatal screening programs in the region. Asia Pacific region is projected to witness fastest growth rate over the forecast period due to emerging economies, rising healthcare expenditure and increasing awareness.

Key players

Key players operating in the preeclampsia diagnostics market are Diabetomics, Inc., Thermo Fisher Scientific Inc., F. Hoffman-La Roche Ltd, PerkinElmer Inc., Siemens Healthineers AG, DRG INSTRUMENTS GMBH, Metabolomic Diagnostics Ltd., Sera Prognostics, MOMM Diagnostics, Miraculins Inc. Market leaders are focusing on new product launches and partnerships to strengthen their foothold in the market. For instance, in August 2022, MOMM Diagnostics launched PeriVision, a CE-marked screening test for preeclampsia in Europe.

Get more insights on this topic:

https://www.dailyprbulletin.com/preeclampsia-diagnostics-market-insights-trends/

collect
0
avatar
naufan
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more